CRYM
Price
$0.03
Change
-$0.00 (-0.00%)
Updated
Jul 3 closing price
Capitalization
27.72M
TKPHF
Price
$28.35
Change
+$0.67 (+2.42%)
Updated
Jun 24 closing price
Capitalization
47.94B
Interact to see
Advertisement

CRYM vs TKPHF

Header iconCRYM vs TKPHF Comparison
Open Charts CRYM vs TKPHFBanner chart's image
Cryomass Technologies
Price$0.03
Change-$0.00 (-0.00%)
Volume$40.4K
Capitalization27.72M
Takeda Pharmaceutical
Price$28.35
Change+$0.67 (+2.42%)
Volume$245
Capitalization47.94B
CRYM vs TKPHF Comparison Chart in %
Loading...
CRYM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TKPHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRYM vs. TKPHF commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRYM is a Hold and TKPHF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (CRYM: $0.03 vs. TKPHF: $28.35)
Brand notoriety: CRYM and TKPHF are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: CRYM: 106% vs. TKPHF: 0%
Market capitalization -- CRYM: $27.72M vs. TKPHF: $47.94B
CRYM [@Pharmaceuticals: Other] is valued at $27.72M. TKPHF’s [@Pharmaceuticals: Other] market capitalization is $47.94B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.8B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRYM’s FA Score shows that 0 FA rating(s) are green whileTKPHF’s FA Score has 2 green FA rating(s).

  • CRYM’s FA Score: 0 green, 5 red.
  • TKPHF’s FA Score: 2 green, 3 red.
According to our system of comparison, TKPHF is a better buy in the long-term than CRYM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRYM’s TA Score shows that 4 TA indicator(s) are bullish while TKPHF’s TA Score has 2 bullish TA indicator(s).

  • CRYM’s TA Score: 4 bullish, 3 bearish.
  • TKPHF’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, CRYM is a better buy in the short-term than TKPHF.

Price Growth

CRYM (@Pharmaceuticals: Other) experienced а -0.29% price change this week, while TKPHF (@Pharmaceuticals: Other) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.13%. For the same industry, the average monthly price growth was +3.08%, and the average quarterly price growth was +93.03%.

Reported Earning Dates

TKPHF is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+2.13% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TKPHF($47.9B) has a higher market cap than CRYM($27.7M). CRYM YTD gains are higher at: 59.170 vs. TKPHF (5.981). TKPHF has higher annual earnings (EBITDA): 1.15T vs. CRYM (-9.46M). TKPHF has more cash in the bank: 369B vs. CRYM (664K). CRYM has less debt than TKPHF: CRYM (2M) vs TKPHF (4.75T). TKPHF has higher revenues than CRYM: TKPHF (4.11T) vs CRYM (0).
CRYMTKPHFCRYM / TKPHF
Capitalization27.7M47.9B0%
EBITDA-9.46M1.15T-0%
Gain YTD59.1705.981989%
P/E RatioN/A22.47-
Revenue04.11T-
Total Cash664K369B0%
Total Debt2M4.75T0%
FUNDAMENTALS RATINGS
CRYM vs TKPHF: Fundamental Ratings
CRYM
TKPHF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
87
Overvalued
8
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9884
PRICE GROWTH RATING
1..100
4957
P/E GROWTH RATING
1..100
10022
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TKPHF's Valuation (8) in the null industry is significantly better than the same rating for CRYM (87). This means that TKPHF’s stock grew significantly faster than CRYM’s over the last 12 months.

TKPHF's Profit vs Risk Rating (100) in the null industry is in the same range as CRYM (100). This means that TKPHF’s stock grew similarly to CRYM’s over the last 12 months.

TKPHF's SMR Rating (84) in the null industry is in the same range as CRYM (98). This means that TKPHF’s stock grew similarly to CRYM’s over the last 12 months.

CRYM's Price Growth Rating (49) in the null industry is in the same range as TKPHF (57). This means that CRYM’s stock grew similarly to TKPHF’s over the last 12 months.

TKPHF's P/E Growth Rating (22) in the null industry is significantly better than the same rating for CRYM (100). This means that TKPHF’s stock grew significantly faster than CRYM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRYMTKPHF
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
48%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
48%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
53%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
46%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
47%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
42%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
Bearish Trend 3 days ago
89%
N/A
BollingerBands
ODDS (%)
N/A
Bearish Trend 3 days ago
55%
Aroon
ODDS (%)
Bullish Trend 3 days ago
86%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CRYM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TKPHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ANGVF0.59N/A
N/A
Angus Gold Inc.
BFLBY17.85N/A
N/A
Bilfinger SE
HOKCF0.84N/A
N/A
Hong Kong & China Gas Co., Ltd.
KMFI0.03N/A
N/A
Keller Manufacturing Company, Inc. (The)
PTCHF1.65N/A
N/A
PureTech Health PLC

CRYM and

Correlation & Price change

A.I.dvisor tells us that CRYM and BGLAF have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CRYM and BGLAF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRYM
1D Price
Change %
CRYM100%
-1.43%
BGLAF - CRYM
22%
Poorly correlated
N/A
AYRWF - CRYM
8%
Poorly correlated
-4.96%
TKPHF - CRYM
3%
Poorly correlated
N/A
TEVJF - CRYM
2%
Poorly correlated
N/A
CLCFF - CRYM
1%
Poorly correlated
N/A
More

TKPHF and

Correlation & Price change

A.I.dvisor tells us that TKPHF and TAK have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TKPHF and TAK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TKPHF
1D Price
Change %
TKPHF100%
N/A
TAK - TKPHF
27%
Poorly correlated
-0.52%
TEVJF - TKPHF
17%
Poorly correlated
N/A
ZTS - TKPHF
16%
Poorly correlated
+0.06%
BHC - TKPHF
15%
Poorly correlated
-0.84%
QNTM - TKPHF
13%
Poorly correlated
-10.96%
More